Industry Research Reports

Home > Reports > Pharma & Healthcare > Diabetes Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Diabetes Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-15

Pages: 171 Pages

Report ld: 2645470

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Diabetes Medicines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Medicines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Medicines by region & country, by Type, and by Application.

The Diabetes Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Medicines.

Market Segmentation

Report Metric
Details
Report Title
Diabetes Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Diabetes Medicines Companies Covered
Sanofi, AstraZeneca, Bayer, Biocon, Boehringer Ingelheim, Dongbao Pharmaceutical, Eli Lilly, Ganlee, Ginwa, Guangzhou Baiyun Mountain, Hisun Pharmacy, Hua Dong, Huadong Medicine, Jumpcan Pharmacy, KELUN, Merck & Co., MSD, North China Pharmaceutical Group Corporation, Novartis, Novo Nordisk, Sanofi, SHIJIAZHUANG YILING PHARMACEUTICAL, Takeda, Taloph, Tianan Pharmaceutical, Tonghua DongBao, Wanbang Biopharmaceuticals
Global Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Medicines Market, Segment by Type
Insulin

DPP-4

GLP-1

SGLT-2
Global Diabetes Medicines Market, Segment by Application
Type 1 Diabetes

Type 2 Diabetes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetes Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diabetes Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diabetes Medicines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Diabetes Medicines Product Introduction
    1.2 Global Diabetes Medicines Market Size Forecast
        1.2.1 Global Diabetes Medicines Sales Value (2019-2030)
        1.2.2 Global Diabetes Medicines Sales Volume (2019-2030)
        1.2.3 Global Diabetes Medicines Sales Price (2019-2030)
    1.3 Diabetes Medicines Market Trends & Drivers
        1.3.1 Diabetes Medicines Industry Trends
        1.3.2 Diabetes Medicines Market Drivers & Opportunity
        1.3.3 Diabetes Medicines Market Challenges
        1.3.4 Diabetes Medicines Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Diabetes Medicines Players Revenue Ranking (2023)
    2.2 Global Diabetes Medicines Revenue by Company (2019-2024)
    2.3 Global Diabetes Medicines Players Sales Volume Ranking (2023)
    2.4 Global Diabetes Medicines Sales Volume by Company Players (2019-2024)
    2.5 Global Diabetes Medicines Average Price by Company (2019-2024)
    2.6 Key Manufacturers Diabetes Medicines Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Diabetes Medicines Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Diabetes Medicines
    2.9 Diabetes Medicines Market Competitive Analysis
        2.9.1 Diabetes Medicines Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Diabetes Medicines Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Insulin
        3.1.2 DPP-4
        3.1.3 GLP-1
        3.1.4 SGLT-2
    3.2 Global Diabetes Medicines Sales Value by Type
        3.2.1 Global Diabetes Medicines Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Diabetes Medicines Sales Value, by Type (2019-2030)
        3.2.3 Global Diabetes Medicines Sales Value, by Type (%) (2019-2030)
    3.3 Global Diabetes Medicines Sales Volume by Type
        3.3.1 Global Diabetes Medicines Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Diabetes Medicines Sales Volume, by Type (2019-2030)
        3.3.3 Global Diabetes Medicines Sales Volume, by Type (%) (2019-2030)
    3.4 Global Diabetes Medicines Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Type 1 Diabetes
        4.1.2 Type 2 Diabetes
    4.2 Global Diabetes Medicines Sales Value by Application
        4.2.1 Global Diabetes Medicines Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Diabetes Medicines Sales Value, by Application (2019-2030)
        4.2.3 Global Diabetes Medicines Sales Value, by Application (%) (2019-2030)
    4.3 Global Diabetes Medicines Sales Volume by Application
        4.3.1 Global Diabetes Medicines Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Diabetes Medicines Sales Volume, by Application (2019-2030)
        4.3.3 Global Diabetes Medicines Sales Volume, by Application (%) (2019-2030)
    4.4 Global Diabetes Medicines Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Diabetes Medicines Sales Value by Region
        5.1.1 Global Diabetes Medicines Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Diabetes Medicines Sales Value by Region (2019-2024)
        5.1.3 Global Diabetes Medicines Sales Value by Region (2025-2030)
        5.1.4 Global Diabetes Medicines Sales Value by Region (%), (2019-2030)
    5.2 Global Diabetes Medicines Sales Volume by Region
        5.2.1 Global Diabetes Medicines Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Diabetes Medicines Sales Volume by Region (2019-2024)
        5.2.3 Global Diabetes Medicines Sales Volume by Region (2025-2030)
        5.2.4 Global Diabetes Medicines Sales Volume by Region (%), (2019-2030)
    5.3 Global Diabetes Medicines Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Diabetes Medicines Sales Value, 2019-2030
        5.4.2 North America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Diabetes Medicines Sales Value, 2019-2030
        5.5.2 Europe Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Diabetes Medicines Sales Value, 2019-2030
        5.6.2 Asia Pacific Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Diabetes Medicines Sales Value, 2019-2030
        5.7.2 South America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Diabetes Medicines Sales Value, 2019-2030
        5.8.2 Middle East & Africa Diabetes Medicines Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Diabetes Medicines Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Diabetes Medicines Sales Value
        6.2.1 Key Countries/Regions Diabetes Medicines Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Diabetes Medicines Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Diabetes Medicines Sales Value, 2019-2030
        6.3.2 United States Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Diabetes Medicines Sales Value, 2019-2030
        6.4.2 Europe Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Diabetes Medicines Sales Value, 2019-2030
        6.5.2 China Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Diabetes Medicines Sales Value, 2019-2030
        6.6.2 Japan Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Diabetes Medicines Sales Value, 2019-2030
        6.7.2 South Korea Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Diabetes Medicines Sales Value, 2019-2030
        6.8.2 Southeast Asia Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Diabetes Medicines Sales Value, 2019-2030
        6.9.2 India Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Diabetes Medicines Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Information
        7.1.2 Sanofi Introduction and Business Overview
        7.1.3 Sanofi Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Sanofi Diabetes Medicines Product Offerings
        7.1.5 Sanofi Recent Development
    7.2 AstraZeneca
        7.2.1 AstraZeneca Company Information
        7.2.2 AstraZeneca Introduction and Business Overview
        7.2.3 AstraZeneca Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 AstraZeneca Diabetes Medicines Product Offerings
        7.2.5 AstraZeneca Recent Development
    7.3 Bayer
        7.3.1 Bayer Company Information
        7.3.2 Bayer Introduction and Business Overview
        7.3.3 Bayer Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Bayer Diabetes Medicines Product Offerings
        7.3.5 Bayer Recent Development
    7.4 Biocon
        7.4.1 Biocon Company Information
        7.4.2 Biocon Introduction and Business Overview
        7.4.3 Biocon Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Biocon Diabetes Medicines Product Offerings
        7.4.5 Biocon Recent Development
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Company Information
        7.5.2 Boehringer Ingelheim Introduction and Business Overview
        7.5.3 Boehringer Ingelheim Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Boehringer Ingelheim Diabetes Medicines Product Offerings
        7.5.5 Boehringer Ingelheim Recent Development
    7.6 Dongbao Pharmaceutical
        7.6.1 Dongbao Pharmaceutical Company Information
        7.6.2 Dongbao Pharmaceutical Introduction and Business Overview
        7.6.3 Dongbao Pharmaceutical Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Dongbao Pharmaceutical Diabetes Medicines Product Offerings
        7.6.5 Dongbao Pharmaceutical Recent Development
    7.7 Eli Lilly
        7.7.1 Eli Lilly Company Information
        7.7.2 Eli Lilly Introduction and Business Overview
        7.7.3 Eli Lilly Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Eli Lilly Diabetes Medicines Product Offerings
        7.7.5 Eli Lilly Recent Development
    7.8 Ganlee
        7.8.1 Ganlee Company Information
        7.8.2 Ganlee Introduction and Business Overview
        7.8.3 Ganlee Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Ganlee Diabetes Medicines Product Offerings
        7.8.5 Ganlee Recent Development
    7.9 Ginwa
        7.9.1 Ginwa Company Information
        7.9.2 Ginwa Introduction and Business Overview
        7.9.3 Ginwa Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Ginwa Diabetes Medicines Product Offerings
        7.9.5 Ginwa Recent Development
    7.10 Guangzhou Baiyun Mountain
        7.10.1 Guangzhou Baiyun Mountain Company Information
        7.10.2 Guangzhou Baiyun Mountain Introduction and Business Overview
        7.10.3 Guangzhou Baiyun Mountain Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Guangzhou Baiyun Mountain Diabetes Medicines Product Offerings
        7.10.5 Guangzhou Baiyun Mountain Recent Development
    7.11 Hisun Pharmacy
        7.11.1 Hisun Pharmacy Company Information
        7.11.2 Hisun Pharmacy Introduction and Business Overview
        7.11.3 Hisun Pharmacy Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Hisun Pharmacy Diabetes Medicines Product Offerings
        7.11.5 Hisun Pharmacy Recent Development
    7.12 Hua Dong
        7.12.1 Hua Dong Company Information
        7.12.2 Hua Dong Introduction and Business Overview
        7.12.3 Hua Dong Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Hua Dong Diabetes Medicines Product Offerings
        7.12.5 Hua Dong Recent Development
    7.13 Huadong Medicine
        7.13.1 Huadong Medicine Company Information
        7.13.2 Huadong Medicine Introduction and Business Overview
        7.13.3 Huadong Medicine Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Huadong Medicine Diabetes Medicines Product Offerings
        7.13.5 Huadong Medicine Recent Development
    7.14 Jumpcan Pharmacy
        7.14.1 Jumpcan Pharmacy Company Information
        7.14.2 Jumpcan Pharmacy Introduction and Business Overview
        7.14.3 Jumpcan Pharmacy Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Jumpcan Pharmacy Diabetes Medicines Product Offerings
        7.14.5 Jumpcan Pharmacy Recent Development
    7.15 KELUN
        7.15.1 KELUN Company Information
        7.15.2 KELUN Introduction and Business Overview
        7.15.3 KELUN Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 KELUN Diabetes Medicines Product Offerings
        7.15.5 KELUN Recent Development
    7.16 Merck & Co.
        7.16.1 Merck & Co. Company Information
        7.16.2 Merck & Co. Introduction and Business Overview
        7.16.3 Merck & Co. Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Merck & Co. Diabetes Medicines Product Offerings
        7.16.5 Merck & Co. Recent Development
    7.17 MSD
        7.17.1 MSD Company Information
        7.17.2 MSD Introduction and Business Overview
        7.17.3 MSD Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 MSD Diabetes Medicines Product Offerings
        7.17.5 MSD Recent Development
    7.18 North China Pharmaceutical Group Corporation
        7.18.1 North China Pharmaceutical Group Corporation Company Information
        7.18.2 North China Pharmaceutical Group Corporation Introduction and Business Overview
        7.18.3 North China Pharmaceutical Group Corporation Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 North China Pharmaceutical Group Corporation Diabetes Medicines Product Offerings
        7.18.5 North China Pharmaceutical Group Corporation Recent Development
    7.19 Novartis
        7.19.1 Novartis Company Information
        7.19.2 Novartis Introduction and Business Overview
        7.19.3 Novartis Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Novartis Diabetes Medicines Product Offerings
        7.19.5 Novartis Recent Development
    7.20 Novo Nordisk
        7.20.1 Novo Nordisk Company Information
        7.20.2 Novo Nordisk Introduction and Business Overview
        7.20.3 Novo Nordisk Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Novo Nordisk Diabetes Medicines Product Offerings
        7.20.5 Novo Nordisk Recent Development
    7.21 Sanofi
        7.21.1 Sanofi Company Information
        7.21.2 Sanofi Introduction and Business Overview
        7.21.3 Sanofi Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.21.4 Sanofi Diabetes Medicines Product Offerings
        7.21.5 Sanofi Recent Development
    7.22 SHIJIAZHUANG YILING PHARMACEUTICAL
        7.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Information
        7.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
        7.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product Offerings
        7.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
    7.23 Takeda
        7.23.1 Takeda Company Information
        7.23.2 Takeda Introduction and Business Overview
        7.23.3 Takeda Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.23.4 Takeda Diabetes Medicines Product Offerings
        7.23.5 Takeda Recent Development
    7.24 Taloph
        7.24.1 Taloph Company Information
        7.24.2 Taloph Introduction and Business Overview
        7.24.3 Taloph Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.24.4 Taloph Diabetes Medicines Product Offerings
        7.24.5 Taloph Recent Development
    7.25 Tianan Pharmaceutical
        7.25.1 Tianan Pharmaceutical Company Information
        7.25.2 Tianan Pharmaceutical Introduction and Business Overview
        7.25.3 Tianan Pharmaceutical Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.25.4 Tianan Pharmaceutical Diabetes Medicines Product Offerings
        7.25.5 Tianan Pharmaceutical Recent Development
    7.26 Tonghua DongBao
        7.26.1 Tonghua DongBao Company Information
        7.26.2 Tonghua DongBao Introduction and Business Overview
        7.26.3 Tonghua DongBao Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.26.4 Tonghua DongBao Diabetes Medicines Product Offerings
        7.26.5 Tonghua DongBao Recent Development
    7.27 Wanbang Biopharmaceuticals
        7.27.1 Wanbang Biopharmaceuticals Company Information
        7.27.2 Wanbang Biopharmaceuticals Introduction and Business Overview
        7.27.3 Wanbang Biopharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        7.27.4 Wanbang Biopharmaceuticals Diabetes Medicines Product Offerings
        7.27.5 Wanbang Biopharmaceuticals Recent Development

 8 Industry Chain Analysis
    8.1 Diabetes Medicines Industrial Chain
    8.2 Diabetes Medicines Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Diabetes Medicines Sales Model
        8.5.2 Sales Channel
        8.5.3 Diabetes Medicines Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Diabetes Medicines Market Trends
    Table 2. Diabetes Medicines Market Drivers & Opportunity
    Table 3. Diabetes Medicines Market Challenges
    Table 4. Diabetes Medicines Market Restraints
    Table 5. Global Diabetes Medicines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Diabetes Medicines Revenue Market Share by Company (2019-2024)
    Table 7. Global Diabetes Medicines Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Diabetes Medicines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Diabetes Medicines Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Diabetes Medicines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Diabetes Medicines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Diabetes Medicines
    Table 13. Global Diabetes Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Diabetes Medicines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Diabetes Medicines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Diabetes Medicines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Diabetes Medicines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Diabetes Medicines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Diabetes Medicines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Diabetes Medicines Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Diabetes Medicines Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Diabetes Medicines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Diabetes Medicines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Diabetes Medicines Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Diabetes Medicines Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Diabetes Medicines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Diabetes Medicines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Diabetes Medicines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Diabetes Medicines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Diabetes Medicines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Diabetes Medicines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Diabetes Medicines Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Diabetes Medicines Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Diabetes Medicines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Diabetes Medicines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Diabetes Medicines Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Diabetes Medicines Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Diabetes Medicines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Diabetes Medicines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Diabetes Medicines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Diabetes Medicines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Diabetes Medicines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Diabetes Medicines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Diabetes Medicines Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Diabetes Medicines Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Diabetes Medicines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Diabetes Medicines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Diabetes Medicines Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Diabetes Medicines Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Diabetes Medicines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Diabetes Medicines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Diabetes Medicines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Diabetes Medicines Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Diabetes Medicines Sales Volume, (2025-2030) & (K Units)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Sanofi Diabetes Medicines Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. AstraZeneca Company Information
    Table 63. AstraZeneca Introduction and Business Overview
    Table 64. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. AstraZeneca Diabetes Medicines Product Offerings
    Table 66. AstraZeneca Recent Development
    Table 67. Bayer Company Information
    Table 68. Bayer Introduction and Business Overview
    Table 69. Bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Bayer Diabetes Medicines Product Offerings
    Table 71. Bayer Recent Development
    Table 72. Biocon Company Information
    Table 73. Biocon Introduction and Business Overview
    Table 74. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Biocon Diabetes Medicines Product Offerings
    Table 76. Biocon Recent Development
    Table 77. Boehringer Ingelheim Company Information
    Table 78. Boehringer Ingelheim Introduction and Business Overview
    Table 79. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Boehringer Ingelheim Diabetes Medicines Product Offerings
    Table 81. Boehringer Ingelheim Recent Development
    Table 82. Dongbao Pharmaceutical Company Information
    Table 83. Dongbao Pharmaceutical Introduction and Business Overview
    Table 84. Dongbao Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Dongbao Pharmaceutical Diabetes Medicines Product Offerings
    Table 86. Dongbao Pharmaceutical Recent Development
    Table 87. Eli Lilly Company Information
    Table 88. Eli Lilly Introduction and Business Overview
    Table 89. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Eli Lilly Diabetes Medicines Product Offerings
    Table 91. Eli Lilly Recent Development
    Table 92. Ganlee Company Information
    Table 93. Ganlee Introduction and Business Overview
    Table 94. Ganlee Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Ganlee Diabetes Medicines Product Offerings
    Table 96. Ganlee Recent Development
    Table 97. Ginwa Company Information
    Table 98. Ginwa Introduction and Business Overview
    Table 99. Ginwa Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Ginwa Diabetes Medicines Product Offerings
    Table 101. Ginwa Recent Development
    Table 102. Guangzhou Baiyun Mountain Company Information
    Table 103. Guangzhou Baiyun Mountain Introduction and Business Overview
    Table 104. Guangzhou Baiyun Mountain Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Guangzhou Baiyun Mountain Diabetes Medicines Product Offerings
    Table 106. Guangzhou Baiyun Mountain Recent Development
    Table 107. Hisun Pharmacy Company Information
    Table 108. Hisun Pharmacy Introduction and Business Overview
    Table 109. Hisun Pharmacy Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Hisun Pharmacy Diabetes Medicines Product Offerings
    Table 111. Hisun Pharmacy Recent Development
    Table 112. Hua Dong Company Information
    Table 113. Hua Dong Introduction and Business Overview
    Table 114. Hua Dong Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Hua Dong Diabetes Medicines Product Offerings
    Table 116. Hua Dong Recent Development
    Table 117. Huadong Medicine Company Information
    Table 118. Huadong Medicine Introduction and Business Overview
    Table 119. Huadong Medicine Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Huadong Medicine Diabetes Medicines Product Offerings
    Table 121. Huadong Medicine Recent Development
    Table 122. Jumpcan Pharmacy Company Information
    Table 123. Jumpcan Pharmacy Introduction and Business Overview
    Table 124. Jumpcan Pharmacy Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Jumpcan Pharmacy Diabetes Medicines Product Offerings
    Table 126. Jumpcan Pharmacy Recent Development
    Table 127. KELUN Company Information
    Table 128. KELUN Introduction and Business Overview
    Table 129. KELUN Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. KELUN Diabetes Medicines Product Offerings
    Table 131. KELUN Recent Development
    Table 132. Merck & Co. Company Information
    Table 133. Merck & Co. Introduction and Business Overview
    Table 134. Merck & Co. Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Merck & Co. Diabetes Medicines Product Offerings
    Table 136. Merck & Co. Recent Development
    Table 137. MSD Company Information
    Table 138. MSD Introduction and Business Overview
    Table 139. MSD Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. MSD Diabetes Medicines Product Offerings
    Table 141. MSD Recent Development
    Table 142. North China Pharmaceutical Group Corporation Company Information
    Table 143. North China Pharmaceutical Group Corporation Introduction and Business Overview
    Table 144. North China Pharmaceutical Group Corporation Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. North China Pharmaceutical Group Corporation Diabetes Medicines Product Offerings
    Table 146. North China Pharmaceutical Group Corporation Recent Development
    Table 147. Novartis Company Information
    Table 148. Novartis Introduction and Business Overview
    Table 149. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Novartis Diabetes Medicines Product Offerings
    Table 151. Novartis Recent Development
    Table 152. Novo Nordisk Company Information
    Table 153. Novo Nordisk Introduction and Business Overview
    Table 154. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Novo Nordisk Diabetes Medicines Product Offerings
    Table 156. Novo Nordisk Recent Development
    Table 157. Sanofi Company Information
    Table 158. Sanofi Introduction and Business Overview
    Table 159. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Sanofi Diabetes Medicines Product Offerings
    Table 161. Sanofi Recent Development
    Table 162. SHIJIAZHUANG YILING PHARMACEUTICAL Company Information
    Table 163. SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
    Table 164. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product Offerings
    Table 166. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
    Table 167. Takeda Company Information
    Table 168. Takeda Introduction and Business Overview
    Table 169. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Takeda Diabetes Medicines Product Offerings
    Table 171. Takeda Recent Development
    Table 172. Taloph Company Information
    Table 173. Taloph Introduction and Business Overview
    Table 174. Taloph Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Taloph Diabetes Medicines Product Offerings
    Table 176. Taloph Recent Development
    Table 177. Tianan Pharmaceutical Introduction and Business Overview
    Table 178. Tianan Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 179. Tianan Pharmaceutical Diabetes Medicines Product Offerings
    Table 180. Tianan Pharmaceutical Recent Development
    Table 181. Tianan Pharmaceutical Company Information
    Table 182. Tonghua DongBao Company Information
    Table 183. Tonghua DongBao Introduction and Business Overview
    Table 184. Tonghua DongBao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 185. Tonghua DongBao Diabetes Medicines Product Offerings
    Table 186. Tonghua DongBao Recent Development
    Table 187. Wanbang Biopharmaceuticals Company Information
    Table 188. Wanbang Biopharmaceuticals Introduction and Business Overview
    Table 189. Wanbang Biopharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 190. Wanbang Biopharmaceuticals Diabetes Medicines Product Offerings
    Table 191. Wanbang Biopharmaceuticals Recent Development
    Table 192. Key Raw Materials Lists
    Table 193. Raw Materials Key Suppliers Lists
    Table 194. Diabetes Medicines Downstream Customers
    Table 195. Diabetes Medicines Distributors List
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diabetes Medicines Product Picture
    Figure 2. Global Diabetes Medicines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Diabetes Medicines Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Diabetes Medicines Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Diabetes Medicines Report Years Considered
    Figure 7. Global Diabetes Medicines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Diabetes Medicines Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Medicines Revenue in 2023
    Figure 10. Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Insulin Picture
    Figure 12. DPP-4 Picture
    Figure 13. GLP-1 Picture
    Figure 14. SGLT-2 Picture
    Figure 15. Global Diabetes Medicines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Diabetes Medicines Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Diabetes Medicines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Diabetes Medicines Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Diabetes Medicines Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Type 1 Diabetes
    Figure 21. Product Picture of Type 2 Diabetes
    Figure 22. Global Diabetes Medicines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Diabetes Medicines Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Diabetes Medicines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Diabetes Medicines Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Diabetes Medicines Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Diabetes Medicines Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Diabetes Medicines Sales Volume (%), (2019-2030)
    Figure 39. United States Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 60. Diabetes Medicines Industrial Chain
    Figure 61. Diabetes Medicines Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The global market for Diabetes Medicines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Medicines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Medicines by region & country, by Type, and by Application.

The Diabetes Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Medicines.

Market Segmentation